Literature DB >> 17957964

Keishikajutsubuto (Guizhi-shu-fu-tang) treatment for refractory accumulation of synovial fluid in a patient with pustulotic arthro-osteitis.

Koichiro Satoh1, Shizuko Takano, Toshio Kobayashi.   

Abstract

We present a patient, a sixty-seven-year-old woman, who had refractory accumulation of synovial fluid in the knee joints with pustulotic arthro-osteitis for more than 10 years. Fifty ml of synovial fluid from her right knee contained 6,480 pg/ml of interleukin-8 (IL-8) and 15,000/mm3 of neutorophils. At first, she was treated with 400 mg/day of indomethacin farnesil (a prodrug that is converted to indomethacin after intestinal absorption) for 24 weeks. Although, the volume of synovial fluid in her right knee had decreased to 35 ml at the 16th week, it increased to 50 ml at the 24th week again. She was treated with Kampo medicine, Keishikajutsubuto (Guizhi-shu-fu-tang). In the present case, Keishikajutsubuto showed more therapeutic effect to pustulotic arthro-osteitis to reduce volume of synovial fluid to almost 0 ml, IL-8 concentration to 673 pg/ml and number of neutrophils to 660/mm3. Our data showed that Keishikajutsubuto might be suitable for this patient to regulate synovial fluid volume, reduce IL-8 concentration in synovial fluid, and block neutrophils migration to synovial fluid compared to indomethacin therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17957964     DOI: 10.5387/fms.53.33

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN: 0016-2590


  4 in total

1.  Effect of kampo medicine on pain and range of motion of osteoarthritis of the hip accompanied by acetabular dysplasia: case report and literature review.

Authors:  Toshiaki Kogure; Takeshi Tatsumi; Tetsuya Shigeta; Hiroshi Fujinaga; Takahisa Sato; Atsushi Niizawa
Journal:  Integr Med Insights       Date:  2011-11-03

2.  Gyejigachulbutang (Gui-Zhi-Jia-Shu-Fu-Tang, Keishikajutsubuto, TJ-18) in Degenerative Knee Osteoarthritis Patients: Lessons and Responders from a Multicenter Randomized Placebo-Controlled Double-Blind Clinical Trial.

Authors:  Myung Kwan Kim; Jungtae Leem; Young Il Kim; Eunseok Kim; Yang Chun Park; Jae-Uk Sul; Hee-Geun Jo; Sang-Hoon Yoon; Jeeyong Kim; Ju-Hyun Jeon; In Chul Jung
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-28       Impact factor: 2.629

3.  Ultrasound-Guided Hydrodissection of an Entrapped Saphenous Nerve After Lower Extremity Varicose Vein Stripping: A Case Report.

Authors:  Kunitaro Watanabe; Joho Tokumine; Alan Kawarai Lefor; Kumi Moriyama; Tomoko Yorozu
Journal:  A A Pract       Date:  2020-01-01

4.  Atractylodin Produces Antinociceptive Effect through a Long-Lasting TRPA1 Channel Activation.

Authors:  Hirosato Kanda; Yanjing Yang; Shaoqi Duan; Yoko Kogure; Shenglan Wang; Emiko Iwaoka; Miku Ishikawa; Saki Takeda; Hidemi Sonoda; Kyoka Mizuta; Shunji Aoki; Satoshi Yamamoto; Koichi Noguchi; Yi Dai
Journal:  Int J Mol Sci       Date:  2021-03-31       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.